Pt with glioblastoma (gbm) began optune therapy on (b)(6) 2015, novocure was informed by pt's spouse that the pt died earlier that morning.Prescribing physician was contacted for add'l info with no response.Cause of death is unk.No adverse events associated with device use were reported.The last day of optune therapy was not known until the equipment was returned to novocure and logfiles downloaded on (b)(6) 2015.Per logfile review, last device use was (b)(6) 2015 at 09:56 and device was functioning as per normal operating parameters.
|
Novocure medical opinion is that the death was not related to optune therapy.Death is an expected event in pts with glioblastoma (gbm) due to the natural history of the disease.Pts with newly diagnosed gbm who are treated with maximal surgical resection, 60 gy radiotherapy together with temozolomide, followed by maintenance temozolomide for 6 months have a median survival of 14.6 months [stupp et al n engl j med 352 (10): 987-96, 2005].
|